Alzheimer's News
Most Popular Alzheimer's Story
Vitae scores $242M Alzheimer's pact with Boehringer
Vitae Pharmaceuticals struck a $242 million deal--$42 million of that as upfront or near term money--to develop Alzheimer's therapies with Boehringer Ingelheim. Vitae stands to earn $200 million in... Read more...
Latest Headlines
- June 15, 2009
- April 2, 2009
- November 18, 2008
- October 22, 2008
- August 20, 2008
- August 4, 2008
- July 30, 2008
- July 18, 2008
- July 15, 2008
- June 17, 2008
- May 5, 2008
- April 25, 2008
- April 18, 2008
- March 12, 2008
- February 25, 2008
- February 8, 2008
- February 4, 2008
- January 31, 2008
- January 25, 2008
Paid Research Reports
- The Top 10 Biosimilar Players: Positioning, performance and SWOT analyses
- New Approaches to Pharma R&D: Evolving strategies to rejuvenate R&D efficiency
- Stakeholder Opinions: Vaccine antigen delivery technologies - Molecular systems to open new markets
- The Top 10 Contract Research Organizations
- Stakeholder Opinions: Vaccine administration technologies - Beyond needles
- Future Pharmaceutical Industry Trends: Long-term opportunities tempered by short-term challenges
